Atara Biotherapeutics Inc (ATRA)
Atara Biotherapeutics Market Cap: 78.27M for May 23, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 23, 2024 | 78.27M |
May 22, 2024 | 84.27M |
May 21, 2024 | 83.48M |
May 20, 2024 | 85.50M |
May 17, 2024 | 73.45M |
May 16, 2024 | 72.68M |
May 15, 2024 | 77.07M |
May 14, 2024 | 72.85M |
May 13, 2024 | 67.00M |
May 10, 2024 | 63.81M |
May 09, 2024 | 65.72M |
May 08, 2024 | 68.10M |
May 07, 2024 | 72.56M |
May 06, 2024 | 75.84M |
May 03, 2024 | 80.68M |
May 02, 2024 | 78.31M |
May 01, 2024 | 82.42M |
April 30, 2024 | 83.09M |
April 29, 2024 | 86.00M |
April 26, 2024 | 83.09M |
April 25, 2024 | 84.27M |
April 24, 2024 | 86.06M |
April 23, 2024 | 86.53M |
April 22, 2024 | 83.98M |
April 19, 2024 | 79.60M |
Date | Value |
---|---|
April 18, 2024 | 83.29M |
April 17, 2024 | 86.09M |
April 16, 2024 | 82.08M |
April 15, 2024 | 81.71M |
April 12, 2024 | 85.19M |
April 11, 2024 | 85.77M |
April 10, 2024 | 86.36M |
April 09, 2024 | 90.16M |
April 08, 2024 | 90.97M |
April 05, 2024 | 93.14M |
April 04, 2024 | 93.72M |
April 03, 2024 | 86.63M |
April 02, 2024 | 87.56M |
April 01, 2024 | 87.24M |
March 28, 2024 | 82.84M |
March 27, 2024 | 83.55M |
March 26, 2024 | 78.90M |
March 25, 2024 | 79.96M |
March 22, 2024 | 83.24M |
March 21, 2024 | 79.85M |
March 20, 2024 | 85.94M |
March 19, 2024 | 81.50M |
March 18, 2024 | 71.09M |
March 15, 2024 | 74.10M |
March 14, 2024 | 67.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
NovaBay Pharmaceuticals Inc | 5.296M |
Palatin Technologies Inc | 32.11M |
iBio Inc | 19.10M |
Theriva Biologics Inc | 5.719M |
Oragenics Inc | 9.768M |
Market Cap Related Metrics
PS Ratio | 2.155 |
PEG Ratio | -0.1269 |
Price | 0.65 |
Earnings Yield | -327.7% |
PEGY Ratio | -0.1269 |